To All who took ACTION requesting THE FDA TO HOLD A STAKEHOLDERS MEETING for ME/CFS: Great job and Thank You!
As a result of your Emails / Letters, patients have been meeting with Congressional offices and support is being gathered from key Representatives.
We do not yet have a meeting set with FDA re: The ME/CFS Stakeholders Meeting.
Therefore, we ask everyone to send in a follow up email / letter.
This letter is directed to FDA Commissioner Margret Hamburg, ensuring that the stakeholder meeting is held. We urge Dr. Hamburg to direct that this critical meeting take place.
PLEASE EMAIL YOUR LETTER DAILY UNTIL June 25th and urge your relatives and friends to do the same. A sample template letter and email addresses are included below. Copy, Paste, add your name etc at the bottom and Send.
YOUR LETTERS COUNT. Remember – LOBBYING & ADVOCACY is how AIDS/HIV got $3 BILLION a year for research, CFS gets $6 million. Hayfever gets more funding! AIDS/HIV sufferers now have multiple drugs to fight the disease. We have NONE. Your previous letter/emails did generate a response, just no confirmed date.
WE MUST KEEP THE HEAT ON, Those who work for our benefit need to Act!
Thank you everyone for taking ACTION for YOUR HEALTH!
From: Your Name June 25, 2012
To: FDA Commissioner Margaret Hamburg, M.D
cc: Janet Woodcock Director CDERFDA, Secretary of Health Kathleen Sebelius, Senator Casey and Congressman Pitts
Subject: Request for FDA Stakeholder Meeting on Chronic Fatigue Syndrome
Dear Dr. Hamburg,
As patients suffering from Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS), we believe your commitment of the FDA holding stakeholder meetings is critical to the FDA understanding and evaluating treatments, particularly to those of us suffering from debilitating/devastating chronic illnesses. As a patient population we are long overdue for treatments and the movement through six divisions at the FDA has contributed to ZERO treatments being available.
We are asking you to convene a “true” stakeholder meeting to examine the treatments currently in use for ME/CFS both in trial and those being used off-label. We anticipate that this meeting will be at least a full day meeting in order to accommodate the experts, clinicians, researchers, patient advocacy groups and patients as well as FDA expertise from a variety of divisions to ensure understanding of this complex illness. With millions of patients suffering from ME/CFS at a cost to our nation of $23 billion, it more than outweighs any cost to the FDA to convene such a meeting. The goal of the meeting is to examine benefit/risk and develop a pathway for the acceleration of treatment, a pathway that can be agreed upon by the ME/CFS community with a commitment by the FDA to change the course of this disease.
As one of the millions of people suffering from ME/CFS, I cannot even dream about a better quality of life because there is simply no avenue to get there. I live every day with a disease that the CDC has said is as disabling as multiple sclerosis, heart disease, end-stage renal disease and similar chronic conditions; AND YET THERE ARE ZERO TREATMENTS TODAY. As this falls within your responsibility to address this “unmet medical need”, please Act Now.
City, State – Zip code